Novavax Jumps on $388 Million Funding From Vaccine Coalition

Published May 11, 2020

Novavax Inc. rallied 20% in after hours trading on Monday after its experimental vaccine for the pandemic sweeping across the globe got a major infusion of cash.

Related Stories